Integrum signs commercial distribution agreement with Labormed for the Slovenian market
Mölndal, Sweden, May 19, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has entered a commercial distribution agreement with Labormed d.o.o., a niche distributor-integrator of medical equipment for orthopaedic treatment clinics in Slovenia. The initial order covers the distribution of OPRA® Implant System units intended for thumb reconstruction surgeries.
Integrum develops and sells OPRA® Implant System, the world’s first prosthetic implant system to reconstruct whole limbs based on osseointegration.
The initial order from Labormed entails OPRA® Implant System units that will be used in reconstructive surgeries in patients who have suffered limb loss at the thumb joint. The order is the first of its kind for Integrum in Slovenia, a market characterized by structured and centralized workflows within the country’s regulatory healthcare agencies.
For more information, please contact:
Martin Hillsten, CEO
Tel: +46 733 55 28 32
Email: martin.hillsten@integrum.se
Certified Adviser
The Company’s Certified Adviser is DNB Carnegie Investment Bank AB.
About integrum
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside of Gothenburg, Sweden, with a U.S. subsidiary in San Francisco. Since 1990, its OPRA™ Implant System has helped improve the quality of life for hundreds of people who are amputees by directly attaching a prosthesis to the bone and musculoskeletal system, therefore avoiding the need for a socket. Based on osseointegration, the bone-anchored implant system offers a range of benefits, including improved mobility and function, enhanced comfort, reduced pressure, a stable attachment and more. The OPRA™ Implant System was approved by the U.S. Food and Drug Administration (FDA) in 2020 and is the only FDA-approved bone-anchored implant system specifically designed for use in amputees available in the U.S. Today, Integrum continues to perform research and develop custom-made medical device solutions in close collaboration with scientists and clinicians. To learn more, please visit https://integrum.se/.